Batch 001 - Live Allocation
Next Release: Aug 2026
Demo · Switch Role
Demo mode. In production, this would be authentication-driven. Each role sees only what's relevant to their workflow.
VL
Vivre Labs
Institutional Longevity
- Peptides -
- Single-vial Blends -
- Goals -
- Clinical Reference -
- Guides -
- Integrity -

§ Legal

Informed Consent & Disclaimer

Status - interim
This consent and disclaimer applies to physician-supervised care delivered through Vivre's clinical partners. Affirmative consent is captured before any prescribed protocol proceeds, following physician assessment. The summary below also appears, in brief, at relevant points on the Platform.
Effective: at clinical launch · Last updated: May 2026

1. Investigational and off-label compounds; regulatory status

Certain compounds available through Vivre's physician-supervised programs are not approved by the U.S. FDA or by the regulatory authority in your jurisdiction for the indication discussed, or are approved only for other indications and used off-label, or remain investigational. Where a compound's approval status is relevant, it is disclosed during your consultation. By proceeding, you acknowledge that you have been informed of the regulatory status of any compound in your protocol and that you are entering a physician-supervised course of treatment with that understanding. Vivre does not supply compounds for self-directed, non-prescribed, or "research" use; all allocation is by physician prescription following clinical assessment.

2. Product quality and supply-chain verification

Vivre takes reasonable, documented steps to verify the identity, purity, and safety of the products it supplies, including independent third-party laboratory testing of sourced material. However, Vivre does not manufacture these compounds and cannot exercise direct control over the manufacturing environment. Vivre therefore does not and cannot guarantee that any product is free from all impurities, variation, or defect. Vivre's responsibility is limited to the verification steps it actually performs and discloses; it makes no warranty of absolute purity or safety beyond those steps.

3. Educational nature of titration and dosing information

All information Vivre provides regarding titration, dosing, administration, and monitoring - on its website, in its guides, through any automated tool, or otherwise - is general educational information only. It is not a prescription, not a dosing recommendation for you, and not a substitute for clinical judgment. Your specific dose, schedule, and suitability are determined solely by your supervising physician based on your individual history, biomarkers, and tolerability. You should not act on any general information without your physician's direction.

4. Assumption of inherent risk

Even under appropriate physician supervision, treatment with these compounds carries inherent risks, including side effects that may be serious. You acknowledge these risks and confirm that you have had the opportunity to discuss them with your physician before proceeding.

5. No waiver of non-waivable rights

Nothing in this consent limits any right or remedy that cannot be waived under the consumer-protection or other applicable law of your jurisdiction.

This document is the interim, pre-launch version. The full, counsel-certified, market-specific versions for Malaysia, Indonesia, and Thailand are being prepared with named local counsel and will replace this document at clinical launch. The operating commitments described - supervised-only clinical care, the data architecture, the non-DTC operating boundary - reflect Vivre\'s deliberate design choices and are not expected to materially change in the final versions.
VL
Vivre Labs
Institutional Longevity

Clinical optimization through institutional medicine. All protocols verified and lot-tested, MSO-administered, hospital-integrated.

V-Series

Peptides

Metabolic
Repair & Aesthetic
Neurological
Growth & Hormonal
Longevity & Immune
Sexual Health

Navigate

Verification

DEMO SITE - PRESENTATION PURPOSES ONLY. All protocols verified and lot-tested, dispensed after comprehensive medical evaluation. Compounds sourced from registered cGMP compounding pharmacies. Individual results vary. MSO structures and revenue models are illustrative for partner conversations. Regulatory outcomes reference publicly disclosed FDA processes and are anticipated but not guaranteed.

© 2026 Vivre Labs. All rights reserved.

cGMPLot-TestedDemo

Demonstration prototype - not a live service